KPIs & Operating Metrics(New)
Growth Metrics

Medtronic (MDT) Cash from Investing Activities (2016 - 2026)

Medtronic's Cash from Investing Activities history spans 13 years, with the latest figure at -$816.0 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 3.2% to -$816.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was -$2.5 billion, a 16.99% decrease, with the full-year FY2025 number at -$1.9 billion, up 18.13% from a year prior.
  • Cash from Investing Activities hit -$816.0 million in Q1 2026 for Medtronic, down from -$482.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for MDT hit a ceiling of $271.0 million in Q2 2022 and a floor of -$1.6 billion in Q3 2022.
  • Historically, Cash from Investing Activities has averaged -$587.0 million across 5 years, with a median of -$490.0 million in 2025.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 84.24% in 2022 and later plummeted 275.28% in 2023.
  • Tracing MDT's Cash from Investing Activities over 5 years: stood at -$1.1 billion in 2022, then soared by 63.0% to -$424.0 million in 2023, then rose by 18.63% to -$345.0 million in 2024, then tumbled by 39.71% to -$482.0 million in 2025, then tumbled by 69.29% to -$816.0 million in 2026.
  • Business Quant data shows Cash from Investing Activities for MDT at -$816.0 million in Q1 2026, -$482.0 million in Q4 2025, and -$719.0 million in Q3 2025.